Sea Crest Wealth Management, LLC Sarepta Therapeutics, Inc. Transaction History

Sea Crest Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 22, 2020	SELL	$76.53 - $135.58 $224,692 - $398,062	-2,936 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$72.81 - $156.91 $6,188 - $13,337	85 Added 2.98%	2,936 $221,000
Q2 2019 Jul 19, 2019	SELL	$112.21 - $151.95 $6,283 - $8,509	-56 Reduced 1.93%	2,851 $433,000
Q1 2019 May 10, 2019	BUY	$106.67 - $151.68 $5,866 - $8,342	55 Added 1.93%	2,907 $346,000
Q4 2018 Feb 13, 2019	BUY	$97.32 - $148.76 $59,073 - $90,297	607 Added 27.04%	2,852 $311,000
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $9,340 - $13,082	-81 Reduced 3.48%	2,245 $363,000
Q2 2018 Aug 03, 2018	BUY	$71.74 - $153.69 $61,911 - $132,634	863 Added 58.99%	2,326 $307,000
Q1 2018 Apr 20, 2018	SELL	$54.02 - $82.27 $155,037 - $236,114	-2,870 Reduced 66.24%	1,463 $108,000
Q4 2017 Feb 02, 2018	BUY	$47.64 - $56.75 $206,424 - $245,897	4,333	4,333 $241,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.